Anticoagulant Choice a Wash in High-Risk ACS
23rd Nov 2005, 03:14 GMT
DURHAM, N.C. - A year's follow-up comparing the anticoagulants Lovenox (enoxaparin) and unfractionated heparin in high-risk acute coronary syndromes showed no significant differences in death or non-fatal heart attack.
Anticoagulant Choice a Wash in High-Risk ACS related news:
- Two anticoagulant therapies for treating acute coronary syndromes show similar outcomes at one year — EurekAlert! - Breaking News
- Auto Accidents Plaintiffs Obtain "No Risk" Lawsuit Loans to Bridge Financial Gap — PR.com Press Releases
- To νέο site του Κέντρου Τεχνών στο ACS «στον αέρα» από την I.M.O. — Pathfinder.gr News - companynews
- Learn from we lawyers: new ACS boss — ZDNet Australia News
- New ACS president named — Top Headlines | ZDNet.com.au
- Also in The News — Adventist News Network
- Bella Vista man honored at ACS meeting — NWAnews.com
- Unión Fenosa sube más de un 4% en Bolsa tras el anuncio de OPA de ACS — ELPAIS.es
- Mehdi Taheri, left, of Snohomish, Wash., and Donna, right, of ... — Top Stories Photos on Yahoo! News Photos
- Unión Fenosa registra fuertes subidas en Bolsa tras el anuncio de OPA de ACS — ELPAIS.es
Latest news from MedPage Today.com Latest Headlines:
- ACAAI: Rodent Exposure Linked to High Asthma Rates in Children
- ACR: Lupus Increases Pregnancy and Disease-Related Risks
- ACAAI: Rush Immunotherapy Provides Rapid Results Safely
- ACR: Small Weight Loss Equals Big Gains In Osteoarthritis Quality Of Life
- Care Found Lacking for Many With Obstructive Lung Disease
- AHA: Actos (pioglitazone) May Slow Progression of Atherosclerosis
- AHA: No Benefit from Late Revascularization After MI for Stable Patients
- AHA: When Stents Fail, Send in the Drug-Coated Balloons
- AHA: When Stents Fail, Send in the Drug-Coated Balloons
- Higher Hemoglobin Targets for Chronic Kidney Disease Linked to Heart Complications